165 related articles for article (PubMed ID: 29846174)
1. Impact of long-term antihypertensive and antidiabetic medications on the prognosis of post-surgical colorectal cancer: the Fujian prospective investigation of cancer (FIESTA) study.
Peng F; Hu D; Lin X; Liang B; Chen Y; Zhang H; Xia Y; Lin J; Zheng X; Niu W
Aging (Albany NY); 2018 May; 10(5):1166-1181. PubMed ID: 29846174
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of long-term antidiabetic and antihypertensive therapy in postoperative gastric cancer patients: the FIESTA study.
Wang L; Hu D; Fan Z; Yu J; Zhang S; Lin Y; Chen X; Lin X; Yan X; Lin J; Peng F
BMC Gastroenterol; 2022 Oct; 22(1):429. PubMed ID: 36210441
[TBL] [Abstract][Full Text] [Related]
3. Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study.
Peng F; Hu D; Lin X; Chen G; Liang B; Zhang H; Ji K; Huang J; Lin J; Zheng X; Niu W
Int J Cancer; 2016 Dec; 139(12):2705-2713. PubMed ID: 27560834
[TBL] [Abstract][Full Text] [Related]
4. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
[TBL] [
